Andreas Pinter - Dissemin

Dissemin is shutting down on January 1st, 2025

Language
Login

All papers authored by Andreas Pinter

This paper was not found in any repository, but could be made available legally by the author.

2023 Lars Iversen, Curdin Conrad

ORCID

, Liv Eidsmo, Antonio Costanzo

ORCID

, Joanna Narbutt, Andreas Pinter

ORCID

, Külli Kingo, Raquel Rivera Diaz

ORCID

, Frank Kolbinger, ManikPrabhu Nanna, Jennifer Annika Frueh, Piotr Jagiello

Secukinumab demonstrates superiority over narrow‐band ultraviolet B phototherapy in new‐onset moderate to severe plaque psoriasis patients: Week 52 results from the STEPIn study

Upload

This paper was not found in any repository, but could be made available legally by the author.

2022 Jonathan I. Silverberg

ORCID

, David N. Adam

ORCID

, Matthew Zirwas

ORCID

ORCID

, Jan Gutermuth

ORCID

, Andreas Pinter

ORCID

, Andrew E. Pink

ORCID

, Andrea Chiricozzi

ORCID

, Sebastien Barbarot

ORCID

ORCID

, Ann-Marie Tindberg

ORCID

, Stephan Weidinger

ORCID

Tralokinumab Plus Topical Corticosteroids as Needed Provides Progressive and Sustained Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Over a 32-Week Period: An ECZTRA 3 Post Hoc Analysis

Upload

This paper was not found in any repository, but could be made available legally by the author.

Matthias Augustin

ORCID

, Kristian Reich

ORCID

, Paul Yamauchi, Andreas Pinter

ORCID

, Jerry Bagel, Swapnil Dahale, Ruquan You, Gerard Bruin, Jimena Djimopoulos, Bertrand Paguet, Pascal Charef, Manmath Patekar, Deborah Keefe

Secukinumab dosing every 2 weeks demonstrated superior efficacy compared with dosing every 4 weeks in patients with psoriasis weighing 90 kg or more: results of a randomized controlled trial*

Upload

This paper was not found in any repository, but could be made available legally by the author.

M. Gooderham

ORCID

, A. Pinter

ORCID

, L. K. Ferris, R. B. Warren, T. Zhan

ORCID

, J. Zeng, A. M. Soliman, C. Kaufmann, B. Kaplan, H. Photowala, B. Strober

ORCID

Long‐term, durable, absolute Psoriasis Area and Severity Index and health‐related quality of life improvements with risankizumab treatment: a post hoc integrated analysis of patients with moderate‐to‐severe plaque psoriasis

Upload

This paper is made freely available by the publisher.

A. Pinter

ORCID

, L. J. Green, J. Selmer, M. Praestegaard, L. S. Gold, M. Augustin

A pooled analysis of randomized, controlled, phase 3 trials investigating the efficacy and safety of a novel, fixed dose calcipotriene and betamethasone dipropionate cream for the topical treatment of plaque psoriasis

Download from onlinelibrary.wiley.com

This paper is made freely available by the publisher.

2021 Mahreen Ameen, Stephan Meller, Andreas Pinter

ORCID

, Neil H. Shear, Angele Soria

Perception and Experience of Biologic Therapy in Atopic Dermatitis: A Qualitative Focus Group Study of Physicians and Patients in Europe and Canada

Download from link.springer.com

This paper is made freely available by the publisher.

Andreas Pinter

ORCID

, Peter Schwarz

ORCID

, Sascha Gerdes, Jan C. Simon, Anja Saalbach

ORCID

, James Rush, Nima Melzer, Thomas Kramps, Benjamin Häberle, Maximilian Reinhardt

Biologic Treatment in Combination with Lifestyle Intervention in Moderate to Severe Plaque Psoriasis and Concomitant Metabolic Syndrome: Rationale and Methodology of the METABOLyx Randomized Controlled Clinical Trial

Download from doi.org

This paper is made freely available by the publisher.

Christian Kromer, Phoebe Wellmann, Ralf Siemer, Selina Klein, Johannes Mohr, Andreas Pinter

ORCID

, Dagmar Wilsmann-Theis, Rotraut Mössner

Influenza Vaccination in Psoriatic Patients—Epidemiology and Patient Perceptions: A German Multicenter Study (Vac-Pso)

Download from doi.org

This paper is made freely available by the publisher.

A. Blauvelt, C. Leonardi, B. Elewski, J. J. Crowley, L. C. Guenther, M. Gooderham, R. G. Langley, R. Vender, A. Pinter

ORCID

, C. E. M. Griffiths, Y. Tada, H. Elmaraghy, R. G. Lima, G. Gallo, L. Renda and 4 other authors

A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 24‐week efficacy and safety results from a randomized, double‐blinded trial*

Download from onlinelibrary.wiley.com

This paper was not found in any repository, but could be made available legally by the author.

D. Thaçi

ORCID

ORCID

, A. Pinter

ORCID

, M. Sebastian, K. Unnebrink, S. Rubant, D. A. Williams, P. Weisenseel

Direct Comparison of Risankizumab and Fumaric Acid Esters in Systemic–Therapy‐Naive Patients With Moderate to Severe Plaque Psoriasis: A Randomized Controlled Trial

Upload

This paper was not found in any repository, but could be made available legally by the author.

J. I. Silverberg

ORCID

, A. Pinter

ORCID

, A. Alavi, C. Lynde, J.‐D Bouaziz

ORCID

, A. Wollenberg

ORCID

, D. F. Murrell, S. Alpizar, V. Laquer, K. Chaouche, F. Ahmad, J. M. Armstrong, C. Piketty

ORCID

Nemolizumab is associated with a rapid improvement in atopic dermatitis signs and symptoms: subpopulation (EASI ≥ 16) analysis of randomized phase 2B study

Upload

This paper is made freely available by the publisher.

A. Pinter

ORCID

, M. Hoffmann, K. Reich, M. Augustin, K. Kaplan, S. D. Gudjónsdóttir, T. Delvin, U. Mrowietz, S. Beissert, I. Effendy, K. Eyerich, L. Gonser, A. Kleinheinz, N. Leitz, J. Niesmann and 16 other authors

A phase 4, randomized, head‐to‐head trial comparing the efficacy of subcutaneous injections of brodalumab to oral administrations of fumaric acid esters in adults with moderate‐to‐severe plaque psoriasis (CHANGE)

Download from onlinelibrary.wiley.com

This paper was not found in any repository, but could be made available legally by the author.

A. Dmitriev, A. König, V. Lang, S. Diehl, R. Kaufmann, A. Pinter

ORCID

ORCID

mTORC1 – a potential player in the pathogenesis of hidradenitis suppurativa?

Upload

This paper was not found in any repository, but could be made available legally by the author.

D. Thaçi, D. A. Williams, Am M. Soliman, K. Eyerich, A. Pinter

ORCID

, M. Sebastian, K. Unnebrink, S. Rubant, DA Williams, P. Weisenseel

Patient‐reported outcomes with risankizumab versus fumaric acid esters in systemic therapy‐naïve patients with moderate to severe plaque psoriasis: a phase 3 clinical trial

Upload

This paper was not found in any repository, but could be made available legally by the author.

2020 A. Leutz, A. Pinter

ORCID

, D. Thaçi, M. Augustin

ORCID

, C. Schuster, K. Fotiou, H. P. Hundemer, D. Saure, U. Mrowietz

ORCID

, K. Reich

ORCID

Efficacy and safety of ixekizumab after switching from fumaric acid esters or methotrexate in patients with moderate‐to‐severe plaque psoriasis naïve to systemic treatment

Upload

This paper is made freely available by the publisher.

A. S. Paller, M. M. B. Seyger, G. Alejandro Magariños, J. Bagel, A. Pinter

ORCID

, J. Cather, S. Keller, C. Rodriguez Capriles, R. Gontijo Lima, G. Gallo, C. A. Little, E. Edson‐Heredia, L. Li, W. Xu, K. Papp

Efficacy and safety of ixekizumab in a phase III , randomized, double‐blind, placebo‐controlled study in paediatric patients with moderate‐to‐severe plaque psoriasis ( IXORA ‐ PEDS )

Download from onlinelibrary.wiley.com

This paper is made freely available by the publisher.

Andreas Pinter

ORCID

, Georgios Kokolakis, Juergen Rech, Mona H. C. Biermann, Benjamin M. Häberle, Jan Multmeier, Maximilian Reinhardt

Hidradenitis Suppurativa and Concurrent Psoriasis: Comparison of Epidemiology, Comorbidity Profiles, and Risk Factors

Download from doi.org

This paper is made freely available by the publisher.

Andreas Pinter

ORCID

, Nicole Mielke, Bartosz Malisiewicz, Roland Kaufmann, Anke König

Management of Paediatric Psoriasis by Paediatricians: A Questionnaire-Based Survey

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

C. Kromer

ORCID

, D. Wilsmann-Theis

ORCID

, S. Gerdes, S. Krebs, A. Pinter

ORCID

, S. Philipp, R. Mössner

ORCID

Changing within the same class: efficacy of brodalumab in plaque psoriasis after treatment with an IL-17A blocker – a retrospective multicenter study

Upload

This paper was not found in any repository, but could be made available legally by the author.

Franziska Stenger, Anke König, Falk Ochsendorf, Roland Kaufmann, Andreas Pinter

ORCID

Correct performance of subcutaneous injections in plaque psoriasis: comparison of trained and untrained patients with different application systems in routine clinical care

Upload

Missing publications? Search for publications with a matching author name.